Clinical Trials
Fragile X Syndrome
- Phase 2 Study of STX209 to Promote Language and Communication in Children with Fragile X Syndrome
- Phase 3 Study of STX209 for Social Withdrawal in Fragile X Syndrome (Ages 5-11)
No comments:
Post a Comment
All feedback, comments, ideas, and cheerful messages welcome!